Key Takeaways
- • Cleveland-Cliffs (CLF) is scheduled to report Q3 2026 earnings before market open on Monday, October 19, 2026, with analysts expecting revenue of about $5.78 billion and earnings of $0.19 per share, according to Finnhub data cited by Quiver Quantitative.
- • Insider activity over the past six months was limited to one open-market sale: EVP and CFO Celso L. Jr. Goncalves sold 214,308 shares for an estimated $2.87 million, with no insider purchases recorded.
- • Institutional positioning was mixed in Q2 2026, with 262 institutions adding CLF shares and 267 reducing positions; Maple Rock Capital Partners cut its stake by 85.1% (17.66 million shares, about $165.8 million), while Slate Path Capital added 9.17 million shares.
- • Q2 2026 consolidated revenue was $5.2 billion, up 5.92% year over year, though the company reported an EPS of -$0.20 that missed estimates.
- • Seven analysts covering the stock over the past six months set a median price target of $11.50, with individual targets ranging from $9.00 to $15.01.
Summary
Cleveland-Cliffs Inc. (NYSE: CLF) is expected to release its third-quarter 2026 earnings before the U.S. market opens on Monday, October 19, 2026, according to Finnhub data reported by Quiver Quantitative. Analysts surveyed expect revenue of approximately $5.78 billion and earnings of $0.19 per share. The company reported second-quarter 2026 consolidated revenues of $5.2 billion, up from $4.9 billion in the first quarter and an increase of 5.92% from the same period a year earlier. Its reported second-quarter EPS of -$0.20 missed consensus estimates, per the publisher's earnings coverage.
Insider activity has been limited. Over the past six months, CLF insiders executed one open-market transaction, a sale by EVP and Chief Financial Officer Celso L. Jr. Goncalves of 214,308 shares for an estimated $2.87 million. Form 4 filings show the sale was executed in early June 2026 at roughly $13.41 per share. No insider purchases were recorded in the period.
Institutional holdings showed a split picture in the most recent quarter. Quiver Quantitative data indicates 262 institutional investors increased CLF positions while 267 reduced them. Among the largest moves, Maple Rock Capital Partners removed 17.66 million shares (-85.1%), an estimated $165.8 million position, and Turiya Advisors Asia exited a 7.66 million share stake. On the buy side, Slate Path Capital added 9.17 million shares (+47.6%), about $86.1 million, Sixth Street Partners Management added 7.90 million shares, and PointState Capital and Avala Global each added more than 6 million shares.
Sell-side sentiment is mixed. Seven analysts issued price targets over the past six months, with a median of $11.50. Targets include $9.00 from Wells Fargo and Barclays, $11.50 from B. of A. Securities, $10.00 from Citigroup, $12.50 from Morgan Stanley, $13.00 from JP Morgan, and $15.01 from GLJ Research. Quiver Quantitative notes that the figures are drawn from its database and may contain ticker-mapping inaccuracies.
Insider activity has been limited. Over the past six months, CLF insiders executed one open-market transaction, a sale by EVP and Chief Financial Officer Celso L. Jr. Goncalves of 214,308 shares for an estimated $2.87 million. Form 4 filings show the sale was executed in early June 2026 at roughly $13.41 per share. No insider purchases were recorded in the period.
Institutional holdings showed a split picture in the most recent quarter. Quiver Quantitative data indicates 262 institutional investors increased CLF positions while 267 reduced them. Among the largest moves, Maple Rock Capital Partners removed 17.66 million shares (-85.1%), an estimated $165.8 million position, and Turiya Advisors Asia exited a 7.66 million share stake. On the buy side, Slate Path Capital added 9.17 million shares (+47.6%), about $86.1 million, Sixth Street Partners Management added 7.90 million shares, and PointState Capital and Avala Global each added more than 6 million shares.
Sell-side sentiment is mixed. Seven analysts issued price targets over the past six months, with a median of $11.50. Targets include $9.00 from Wells Fargo and Barclays, $11.50 from B. of A. Securities, $10.00 from Citigroup, $12.50 from Morgan Stanley, $13.00 from JP Morgan, and $15.01 from GLJ Research. Quiver Quantitative notes that the figures are drawn from its database and may contain ticker-mapping inaccuracies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.